Our paper was selected as Editor's pick in the #AACjournal current issue! 👏👏 Check this story on repurposing fenbendazole to fight cryptococcosis!! #Science #mycology #Cryptococcus aac.asm.org/content/64/6/e…
#AACJournal In Press 🔖 Winchell and team demonstrate that a weight-based dosing regimen of IV or powder for oral suspension (PFS) posaconazole is appropriate for pediatric patients at risk for fungal disease, supporting current US labeling doi.org/10.1128/aac.01… Cesar Arias
NEW 🔥review article #AACJournal
Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside. #IDTwitter
aac.asm.org/content/early/…
Thrilled to see SuperTrans Medical pre-clinical findings for our lead clinical candidate #STM001 have been published in the April ed. of AAC Journal by ASM. An important step forward to deliver much needed therapies to tackle #AMR
Check it out: aac.asm.org/content/65/4/e…
Congrats to our talented #AACJournal Editorial Board Members Helen Zgurskaya and W. Scott Moye-Rowley on their election as Fellows of the American Academy of Microbiology! 🎉 Helen Zgurskaya Scott Moye-Rowley
asm.org/Press-Releases…
ASM Cesar Arias
In P. aeruginosa, quorum sensing-regulated production of the blue-colored virulence factor, pyocanin, enhances bacterial resistance to ciprofloxacin. Learn more in #AACJournal : asm.social/1MW
In our new paper in Antimicrobial Agents and Chemotherapy #AACjournal Unnati Chauhan and Valdir Barth @valdirbarth.bsky.social identified two tRNAfMet-inactivating toxins that can be exploited for development of antituberculars journals.asm.org/doi/10.1128/aa…
Happy to have contributed to this superb study in #AACJournal ASM (tinyurl.com/sd52y9ta)! #AMR against our most common #antibiotics is mainly due to #lactamase #enzymes , and carrying multiple at once shape #evolution of higher-level #resistance .
A new study in #AACJournal defines antibiotic response signatures for 17 clinically important tuberculosis drugs by pooling publicly available M. tuberculosis transcriptomic data, revealing the rapid & drug-specific responses of Mtb to antibiotic exposure. asm.social/1Oy
My first paper is out! Describing the activity of 350 epigenetic inhibitors against Plasmodium falciparum blood stages. Check it out aac.asm.org/content/64/7/e… Björn F.C. Kafsack #AACjournal ASM
Combination Therapy with #Ibrexafungerp and #Isavuconazole for Treatment of Experimental Invasive Pulmonary #Aspergillosis (in 🐇 🐇)
From Tom Walsh’s lab in #AACjournal
aac.asm.org/content/early/…
Why Phage Therapy Fails, new podcast ep from #AACJournal EIC Cesar Arias and guest Dr. Saima Aslam. They dive deep into the current state of phage therapy, including the logistical challenges of getting this highly specific therapy to the patient. youtube.com/watch?v=MkJWwD…
Preventive nasal administration of flagellin restores the effect of gentamicin against multidrug-resistant strains of P. aeruginosa. The results, reported in #AACJournal , provide a basis for using flagellin in patients with chronic respiratory diseases. asm.social/1MJ
Disulfiram is used to treat alcoholism—but can it also be used to combat parasites? This #AACJournal report reveals that the drug is effective against cyst stages of the diarrhea-inducing protozoan parasite, Entamoeba histolytica. Learn more: asm.social/Sq
Bacterial pathogens are confronted with a range of challenges during infection. This #AACJournal study explores how hypoxia, a common physiological stress at infection sites, increases the cost of acquiring tetracycline resistance in Staphylococcus aureus. asm.social/WR
The genus Orthopoxvirus includes #monkeypox virus & variola virus, the causative agent of smallpox. Learn in #AACJournal how researchers identified small molecule antipoxviral agents that could potentially be developed as antiviral therapy: asm.social/RN
Dear friends, check out our new paper, title says it all:
'The good, the bad & the hoax: when publication instantaneously impacts treatment strategies for COVID-19', published in #AACJournal (ASM)
> aac.asm.org/content/early/…
#COVID19 #Covid_19 #HCQ #PharmaFacts